A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

New Clinical Trial Shows COVID-19 Vaccines Rapidly Lose Effectiveness


A clinical trial funded by the National Institute of Allergy and Infectious Diseases shows that while COVID-19 vaccines initially enable the body to produce high levels of antibodies to the Omicron variant of SARS-CoV-2, this response decreases rapidly within 3 months. The trial included adults who had completed the initial recommended dosing schedule for any of the vaccines with Emergency Use Authorization from the United States Food and Drug Administration and who also had received a booster shot. The results suggest that a booster schedule to address emerging variants is needed. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy